SUNRISE GENETICS IS LEADING THE FIRST-EVER CANNABIS WORKSHOP AT THE PLANT AND ANIMAL GENOME CONFERENCE IN CALIFORNIA
FOR IMMEDIATE RELEASE
FORT COLLINS, CO – January 11, 2018 - Sunrise Genetics, Inc., the parent company of Marigene and Hempgene, has been selected to organize a cannabis genomics panel at the 26th Annual Plant and Animal Genome Conference held in San Diego, 2018. The featured scientists will be discussing the results of decades-long research that has led to huge strides within the industry and genomics as a whole, despite federal and financial setbacks. The inaugural workshop is titled "Cannabis Genomics: Advances and Applications“, and will feature Dr. CJ Schwartz and Christopher Grassa from Sunrise Genetics, along with leading industry researchers in the field, Dr. George Weiblen, University of Minnesota, USA; Dr. Graham King, Southern Cross University, Australia; Dr. Jon Page, University of British Columbia, Canada; and Dr. John McKay, Colorado State University, USA, discussing past and current research focused on generating genomic tools for Cannabis to further the development of dedicated cultivars for the emerging Cannabis industry.
Understanding the plant and its genetics is fundamental to making the crop a financially lucrative commodity; after all, as Dr. CJ Schwartz states, “No plant on the planet has had a greater influence on human culture, having been cultivated for multiple purposes for millennia.”
The Plant and Animal Genome Conference is the most prestigious Ag-Genomics meeting in the world bringing together over 3,000 leading genetic scientists and researchers in plant and animal research. The conference takes place January 13-17, 2018. For more information or to register for the event, visit: http://www.intlpag.org/.
About Sunrise Genetics
Sunrise Genetics develops and applies genomic tools to understand and guide the development of the Cannabis plant.
We partner with industry leading Cannabis cultivators and breeders to apply evolving genomic knowledge to target improvement of desired traits, accelerate breeding, and unlock the opportunities of Cannabis. The plant knowledge held by our partners, paired with the plant’s DNA, means genetic plant identification and more, it’s the platform for leveraging modern genomics to create a legitimate, commercial-ready plant or varietal line.
To learn more about Sunrise Genetics, visit www.sunrisegenetics.com.
Lexi Valenti, Strategic Development, Sunrise Genetics